BioSpace News Archive

Business

Magellan Health Appoints Derrick Duke as Chief Executive Officer

Magellan Health, Inc. today announced that Derrick Duke has been appointed chief executive officer, succeeding former CEO Ken Fasola. Fasola has been named the executive vice president, Health Care Enterprises (HCE) at Centene.

July 7, 2022
·
2 min read
Biotech Beach

ChromaDex To Host Key Opinion Leader Webinar on the Transforming Benefits of Nicotinamide Riboside (NR)

ChromaDex Corp. announced that it will host a key opinion leader webinar on the transforming benefits of nicotinamide riboside on Wednesday, July 20, 2022 at 11:00 am Eastern Time.

July 7, 2022
·
5 min read
Bausch + Lomb and Novaliq Announce Submission of New Drug Application for Investigational Treatment NOV03 (Perfluorohexyloctane)

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), today announced the submission of a New Drug Application (NDA) at the end of June to the U.S. Food and Drug Administration (FDA) seeking approval for NOV03 (perfluorohexyloctane).

July 7, 2022
·
6 min read
Genetown

Mercy St. Louis Begins Treatment With Mevion Compact Proton Therapy System

Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that the first patient was treated at the David C. Pratt Cancer Center at Mercy Hospital St. Louis on July 5th with the MEVION S250i Proton Therapy System ® .

July 7, 2022
·
4 min read
Genetown

iSpecimen Adds New Global Biospecimen Suppliers to Proprietary Marketplace Platform for Researchers to Leverage

iSpecimen Inc. announced today that it has added new global biospecimen suppliers to its proprietary Marketplace platform for advancing oncology and cardiovascular disease research.

July 7, 2022
·
3 min read
Pharm Country

BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center

BioSig Technologies, Inc. today announced that Kansas City Heart Institute at Overland Park Regional Medical Center in Kansas City, U.S. has signed a purchase agreement to acquire its PURE EP(T.M.) System.

July 7, 2022
·
6 min read
Drug Development

Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in a Lung Fibrosis Model

Galmed Pharmaceuticals Ltd. announced today results showing significant effects of Aramchol in pre-clinical model of both lung and gastrointestinal (GI) fibrosis.

July 7, 2022
·
6 min read
FDA

Renovia receives FDA clearance for leva® Pelvic Health System as first-line treatment for chronic fecal incontinence

Renovia Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its leva ® Pelvic Health System for the first-line treatment of chronic fecal incontinence (FI) in women.

July 7, 2022
·
6 min read
BioCapital

Remidio’s Medios AI shows significant promise in last-mile Screening for Referable Glaucoma

Glaucoma, one of the world’s leading causes of irreversible blindness, is expected to affect an estimated 120 million by 2040, globally.

July 7, 2022
·
3 min read
Pharm Country

Insilico Medicine identified multiple new targets for amyotrophic lateral sclerosis (ALS) using its AI-driven target discovery engine

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has identified multiple unreported potential therapeutic targets for amyotrophic lateral sclerosis (ALS).

July 7, 2022
·
5 min read